Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)

NCT02343939 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Entospletinib
DRUG: Daunorubicin
DRUG: Cytarabine
DRUG: Decitabine
DRUG: Azacitidine

Sponsor

Gilead Sciences